Superantigen expression is driven by both mouse mammary tumor virus long terminal repeat-associated promoters in transgenic mice

Journal of Virology

Volumn 74, Issue 6, 2000, Pages 2900-2902

  Salmons, Brian ^a   Miethke, Thomas ^b   Wintersperger, Stefan ^c   Müller, Mathias ^d   Brem, Gottfried ^d   Günzburg, Walter H ^c,d  

^a Bavarian Nordic GmbH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; LONG TERMINAL REPEAT; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, VIRAL; GENE EXPRESSION REGULATION, VIRAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); SUPERANTIGENS; TERMINAL REPEAT SEQUENCES;

EID: 0033997989     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.6.2900-2902.2000     Document Type: Article

References (18)

1. Acha-Orbea, H., and H. R. MacDonald. 1995. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13:459-486.
2. Acha-Orbea, H., A. N. Shakov, L. Scarpellino, E. Kolb, V. Muller, A. Vessaz-Shaw, R. Fuchs, K. Blochlinger, P. Rollini, J. Billotte, M. Sarafidou, H. R. MacDonald, and H. Diggelmann. 1991. Clonal deletion of Vβ14-bearing T cells in mice transgenic for mammary tumour virus. Nature 350:207-211.
3. Brem, G. 1998. Transgene nutztiere. Zuchtungskunde 60:248-262.
4. Golovkina, T. V., A. Chervonsky, J. P. Dudley, and S. R. Ross. 1992. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69:637-645.
5. Golovkina, T. V., A. B. Jaffe, and S. R. Ross. 1994. Co-expression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range. J. Virol. 68:5019-5026.
6. Golovkina, T. V., O. Prakash, and S. R. Ross. 1996. Endogenous mouse mammary tumor virus Mtv-17 is involved in Mtv-2-induced tumorigenesis in GR mice. Virology 218:14-22.
7. Golovkina, T. V., I. Piazzon, I. Nepomnaschy, V. Buggiano, M. de Olano Vela, and S. R. Ross. 1997. Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses. J. Virol. 71:3895-3903.
8. Günzburg, W. H., F. Heinemann, S. Wintersperger, T. Miethke, H. Wagner, V. Erfle, and B. Salmons. 1993. Endogenous superantigen expression controlled by a novel promoter located in the MMTV long terminal repeat. Nature 354:154-158.
9. Günzburg, W. H., R. M. Saller, and B. Salmons. 1995. Retroviral vectors directed to predefined cell types for gene therapy. Biologicals 23:5-12.
10. Miller, C. L., R. Garner, and V. Paetkau. 1992. An activation-dependent, T-lymphocyte-specific transcriptional activator in the mouse mammary tumor virus env gene. Mol. Cell. Biol. 12:3262-3272.
11. Reuss, F., and J. M. Coffin. 1998. Mouse mammary tumor virus superantigen expression in B cells is regulated by a central enhancer within the pol gene. J. Virol. 72:6073-6082.
12. Salmons, B., and W. H. Günzburg. 1987. Current perspectives in the biology of mouse mammary tumour virus. Virus Res. 8:81-102.
13. Salmons, B., B. Groner, C.-M. Calberg-Bacq, and H. Ponta. 1985. Production of mouse mammary tumour virus upon transfection of a recombinant proviral DNA into cultured cells. Virology 144:101-114.
14. Salmons, B., S. Wintersperger, and W. H. Günzburg. 1994. On the generation of endogenous superantigen diversity. Immunol. Today 15:191-192.
15. Sambasivarao, D., and V. Paetkau. 1996. Interactions of a transcriptional activator in the env gene of the mouse mammary tumor virus with activation-dependent, T cell-specific transacting factors. J. Biol. Chem. 271:8942-8950.
16. Wintersperger, S., S. Indraccolo, T. Miethke, W. H. Günzburg, and B. Salmons. 1994. A transient assay for gene expression studies in B-lymphocytes and its use for superantigen assays. BioTechniques 16:882-886.
17. Wintersperger, S., B. Salmons, T. Miethke, V. Erfle, H. Wagner, and W. H. Günzburg, 1995. Negative acting factor and superantigen are separable activities encoded by the mouse mammary tumor virus long terminal repeat. Proc. Natl. Acad. Sci. USA 92:2745-2749.
18. Zhang, D.-J., V. K. Tsiagbe, C. Huang, and G. J. Thorbecke. 1996. Control of endogenous mouse mammary tumor virus superantigen expression in SJL lymphomas by a promoter within the env region. J. Immunol. 157:3510-3517.